HomeCompareCAH vs CDNS

CAH vs CDNS: Dividend Comparison 2026

CAH yields 0.99% · CDNS yields 0.74%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 CAH wins by $841.00 in total portfolio value
10 years
CAH
CAH
● Live price
0.99%
Share price
$206.31
Annual div
$2.04
5Y div CAGR
5.6%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$21.6K
Annual income
$185.04
Full CAH calculator →
CDNS
CDNS
● Live price
0.74%
Share price
$270.88
Annual div
$2.00
5Y div CAGR
0%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$20.7K
Annual income
$77.46
Full CDNS calculator →

Portfolio growth — CAH vs CDNS

📍 CAH pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodCAHCDNS
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, CAH + CDNS cover 0 of 12 monthsgood coverage

Jan
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec
CAH pays
CDNS pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

CAH
Annual income on $10K today (after 15% tax)
$83.95/yr
After 10yr DRIP, annual income (after tax)
$157.28/yr
CDNS
Annual income on $10K today (after 15% tax)
$62.76/yr
After 10yr DRIP, annual income (after tax)
$65.84/yr
At 15% tax rate, CAH beats the other by $91.44/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of CAH + CDNS for your $10,000?

CAH: 50%CDNS: 50%
100% CDNS50/50100% CAH
Portfolio after 10yr
$21.1K
Annual income
$131.25/yr
Blended yield
0.62%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on CDNS right now

CAH
Analyst Ratings
18
Buy
15
Hold
Consensus: Buy
Price Target
$252.33
+22.3% upside vs current
Range: $220.00 — $275.00
Altman Z
4.8
Piotroski
5/9
CDNS
Analyst Ratings
25
Buy
4
Hold
1
Sell
Consensus: Buy
Price Target
$377.88
+39.5% upside vs current
Range: $275.00 — $418.00
Altman Z
10.9
Piotroski
6/9
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

CAH buys
0
CDNS buys
9
PoliticianChamberTickerTypeAmountDate
Michael McCaul🏢 House$CDNS▼ Sell$1,001 - $15,0002025-10-27
Val Hoyle🏢 House$CDNS▼ Sell$1,001 - $15,0002025-09-23
Ro Khanna🏢 House$CDNS▲ Buy$1,001 - $15,0002025-08-26
Gilbert Cisneros🏢 House$CDNS▼ Sell$1,001 - $15,0002025-08-05
Michael McCaul🏢 House$CDNS▼ Sell$15,001 - $50,0002025-06-16
Jefferson Shreve🏢 House$CDNS▼ Sell$50,001 - $100,0002025-05-12
Greg Landsman🏢 House$CDNS▼ Sell$1,001 - $15,0002025-03-27
Rob Bresnahan🏢 House$CDNS▲ Buy$1,001 - $15,0002025-03-17
Gilbert Cisneros🏢 House$CDNS▼ Sell$1,001 - $15,0002025-02-26
Rob Bresnahan🏢 House$CDNS▼ Sell$1,001 - $15,0002025-01-13
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricCAHCDNS
Forward yield0.99%0.74%
Annual dividend / share$2.04$2.00
Payout ratio50%50%
1-year div growth0%0%
5-year div CAGR5.6%0%
Portfolio after 10y$21.6K$20.7K
Annual income after 10y$185.04$77.46
Total dividends collected$1.4K$758.00
Payment frequencyquarterlyquarterly
SectorHealthcareTechnology
Analyst consensusBuyBuy
Analyst price target$252.33$377.88

Year-by-year: CAH vs CDNS ($10,000, DRIP)

YearCAH PortfolioCAH Income/yrCDNS PortfolioCDNS Income/yrGap
1← crossover$10,804$104.30$10,774$73.83+$30.00CAH
2$11,672$111.21$11,602$74.34+$70.00CAH
3$12,607$118.57$12,489$74.82+$118.00CAH
4$13,616$126.40$13,439$75.27+$177.00CAH
5$14,704$134.73$14,455$75.70+$249.00CAH
6$15,877$143.59$15,543$76.10+$334.00CAH
7$17,142$153.02$16,708$76.47+$434.00CAH
8$18,504$163.04$17,954$76.82+$550.00CAH
9$19,973$173.70$19,288$77.15+$685.00CAH
10$21,557$185.04$20,716$77.46+$841.00CAH

CAH vs CDNS: Complete Analysis 2026

CAHHealthcare

Cardinal Health, Inc. operates as an integrated healthcare services and products company in the United States, Canada, Europe, Asia, and internationally. It provides customized solutions for hospitals, healthcare systems, pharmacies, ambulatory surgery centers, clinical laboratories, physician offices, and patients in the home. The company operates in two segments, Pharmaceutical and Medical. The Pharmaceutical segment distributes branded and generic pharmaceutical, specialty pharmaceutical, and over-the-counter healthcare and consumer products. The segment also provides services to pharmaceutical manufacturers and healthcare providers for specialty pharmaceutical products; operates nuclear pharmacies and radiopharmaceutical manufacturing facilities; repackages generic pharmaceuticals and over-the-counter healthcare products; and offers medication therapy management and patient outcomes services to hospitals, other healthcare providers, and payers, as well as provides pharmacy management services to hospitals. The Medical segment manufactures, sources, and distributes Cardinal Health branded medical, surgical, and laboratory products and devices that include exam and surgical gloves; needles, syringe, and sharps disposals; compressions; incontinences; nutritional delivery products; wound care products; single-use surgical drapes, gowns, and apparels; fluid suction and collection systems; urology products; operating room supply products; and electrode product lines. The segment also distributes a range of national brand products, including medical, surgical, and laboratory products; provides supply chain services and solutions to hospitals, ambulatory surgery centers, clinical laboratories, and other healthcare providers; and assembles and sells sterile, and non-sterile procedure kits. The company was incorporated in 1979 and is headquartered in Dublin, Ohio.

Full CAH Calculator →

CDNSTechnology

Cadence Design Systems, Inc. provides software, hardware, services, and reusable integrated circuit (IC) design blocks worldwide. The company offers functional verification services, including emulation and prototyping hardware. Its functional verification offering consists of JasperGold, a formal verification platform; Xcelium, a parallel logic simulation platform; Palladium, an enterprise emulation platform; and Protium, a prototyping platform for chip verification. The company also provides digital IC design and sign off products, including Genus logic synthesis and Joules RTL power solutions, as well as Modus software solution to reduce systems-on-chip design-for-test time; physical implementation tools, such as place and route, optimization, and multiple patterning preparation; and signoff products to signoff the design as ready for silicon manufacturing. In addition, it offers custom IC design and simulation products to create schematic and physical representations of circuits down to the transistor level for analog, mixed-signal, custom digital, memory, and radio frequency designs; and system design and analysis products to develop printed circuit boards and IC packages, as well as to analyze electromagnetic, electro-thermal, and other multi-physics effects. Further, the company provides intellectual property (IP) products comprising pre-verified and customizable functional blocks to integrate into customer's ICs; and verification IP and memory models to emulate and model the expected behavior and interaction of standard industry system interface protocols. Additionally, it offers services related to methodology, education, and hosted design solutions, as well as technical support and maintenance services. The company serves 5G communications, aerospace and defense, automotive, industrial and healthcare, mobile, consumer, and hyperscale computing markets. Cadence Design Systems, Inc. was incorporated in 1987 and is headquartered in San Jose, California.

Full CDNS Calculator →
📬

Get this CAH vs CDNS comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

CAH vs SCHDCAH vs JEPICAH vs OCAH vs KOCAH vs MAIN

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.